2 news items
IDEXX Laboratories Announces First Quarter Results
IDXX
1 May 24
% as reported and organic for the quarter. Solid gains in the U.S. and Europe were offset by lower Asia Pacific revenues, including impacts from
West Pharmaceutical Q1 Earnings Beat, HVP Sales Weak
BDX
ECL
IDXX
25 Apr 24
, higher Contract Manufacturing component sales and continued demand for NovaPure and self-injection device platforms partially offset the decline
- Prev
- 1
- Next